Ocugen, Inc.
OCGN
$1.04
$0.032.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.75M | 4.52M | 4.06M | 4.70M | 7.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.75M | 4.52M | 4.06M | 4.70M | 7.26M |
| Cost of Revenue | 25.59M | 26.09M | 25.75M | 25.23M | 24.17M |
| Gross Profit | -20.83M | -21.56M | -21.69M | -20.53M | -16.91M |
| SG&A Expenses | 25.81M | 26.74M | 26.69M | 25.53M | 28.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.14M | 61.56M | 58.81M | 57.14M | 58.88M |
| Operating Income | -55.39M | -57.04M | -54.76M | -52.44M | -51.62M |
| Income Before Tax | -56.94M | -57.48M | -54.05M | -51.14M | -49.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.94 | -57.48 | -54.05 | -51.14 | -49.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.94M | -57.48M | -54.05M | -51.14M | -49.89M |
| EBIT | -55.39M | -57.04M | -54.76M | -52.44M | -51.62M |
| EBITDA | -52.34M | -54.34M | -52.79M | -50.89M | -50.51M |
| EPS Basic | -0.20 | -0.21 | -0.20 | -0.19 | -0.19 |
| Normalized Basic EPS | -0.12 | -0.13 | -0.13 | -0.12 | -0.12 |
| EPS Diluted | -0.20 | -0.21 | -0.20 | -0.19 | -0.19 |
| Normalized Diluted EPS | -0.12 | -0.13 | -0.13 | -0.12 | -0.12 |
| Average Basic Shares Outstanding | 1.15B | 1.12B | 1.08B | 1.05B | 1.03B |
| Average Diluted Shares Outstanding | 1.15B | 1.12B | 1.08B | 1.05B | 1.03B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |